CN Patent

CN104725380A — 卢索替尼的氘代衍生物

Assigned to Sun Pharmaceutical Industry Co ltd · Expires 2015-06-24 · 11y expired

What this patent protects

本发明涉及卢索替尼的氘代衍生物。本发明的一种实施方案提供了式A的化合物或其药学上可接受的盐、含有所述化合物的药物组合物以及治疗本文公开的适应症的方法。

USPTO Abstract

本发明涉及卢索替尼的氘代衍生物。本发明的一种实施方案提供了式A的化合物或其药学上可接受的盐、含有所述化合物的药物组合物以及治疗本文公开的适应症的方法。

Drugs covered by this patent

deuruxolitinib-phosphate (DEURUXOLITINIB PHOSPHATE)

Patent Metadata

Patent number: CN104725380A
Jurisdiction: CN
Classification: —
Expires: 2015-06-24
Drug substance claim: No
Drug product claim: No
Assignee: Sun Pharmaceutical Industry Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.